Healthcare -
Biotechnology - NASDAQ - US
$ 11.235
-1.01 %
$ 474 M
Market Cap
-3.72
P/E
URGN - COMMON STOCK
Common Stock URGN - UroGen Pharma Ltd.
89 K
LAST VALUE
20.79%
2 YEAR CAGR
15.13%
5 YEAR CAGR
46.16%
10 YEAR CAGR